Office of Compliance appoints policy director
Executive Summary
Deborah Autor named CDER Office of Compliance Associate Director for Compliance Policy; she was Department of Justice lead counsel in the case that won FDA its right to collect "disgorgement fees" for GMP violations (1"The Pink Sheet" Oct. 23, 2000, p. 4). In her newly created position, Autor reports to Office of Compliance Acting Director David Horowitz...
You may also be interested in...
CDER Compliance Office Head Horowitz Is Former Associate Chief Counsel
The Center for Drug Evaluation & Research Office of Compliance will be led by a director with experience in litigation and policy development rather than a background in the field offices.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.